RB1 and cancer: In squamous cell carcinoma, the occurrences of CDKN2A (27%) and PTEN (17%) mutations become more frequent compared to other cancer subtypes, while in small cell carcinoma, RB1 mutations become more prevalent (40%) (Fig. 6a).